Literature DB >> 20835751

Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids.

Jesper Kolenda1, Stine Skov Jensen, Charlotte Aaberg-Jessen, Karina Christensen, Claus Andersen, Nils Brünner, Bjarne Winther Kristensen.   

Abstract

Tumor hypoxia has been attributed to play a crucial role in tumorigenesis and therapeutic resistance. Recently, it has been suggested that hypoxia leads to and maintains the undifferentiated state of tumor stem cells, thereby contributing to chemoresistance. The aim of the present study is to investigate the influence of hypoxia on the protein expression of a panel of stem cell and chemoresistance markers using in vivo-like multicellular tumor spheroids derived from a glioblastoma short-term culture with tumor stem cell properties (SJ-1) as well as a conventional glioblastoma cell line (U87). Spheroids were formed in 21% and 1% O(2) in serum-free medium. The immunohistochemical panel included hypoxia (HIF-1α, HIF-2α), proliferation (Ki-67), and stem cell markers (CD133, podoplanin, Bmi-1, nestin, Sox-2) as well as markers related to chemoresistance (MGMT, TIMP-1, Lamp-1, MRP1, MDR-1). As spheroids derived in hypoxia were smaller than in normoxia, a set of experiments was included in which the culturing time of hypoxic spheroids was extended to obtain equally sized spheroids. The results showed that expression of HIF-1α and HIF-2α was increased in hypoxia, whereas Ki-67 was reduced. Expression of stem cell markers CD133, podoplanin, Bmi-1, and nestin was increased in hypoxia, whereas Sox-2 was increased in SJ-1 only. TIMP-1 and Lamp-1 were increased in both SJ-1 and U87. In conclusion, the tumor cell phenotype related to stemness, and thereby potentially to chemoresistance, seems to depend on the oxygen tension, suggesting that development of therapeutic strategies targeting tumor stem cells should take oxygen tension into account.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835751     DOI: 10.1007/s11060-010-0357-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  86 in total

1.  Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions.

Authors:  Rachel Glicklis; Jose C Merchuk; Smadar Cohen
Journal:  Biotechnol Bioeng       Date:  2004-06-20       Impact factor: 4.530

2.  Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology.

Authors:  Ilyas Singec; Rolf Knoth; Ralf P Meyer; Jaroslaw Maciaczyk; Benedikt Volk; Guido Nikkhah; Michael Frotscher; Evan Y Snyder
Journal:  Nat Methods       Date:  2006-10       Impact factor: 28.547

Review 3.  The magic of the hypoxia-signaling cascade.

Authors:  E Benizri; A Ginouvès; E Berra
Journal:  Cell Mol Life Sci       Date:  2008-04       Impact factor: 9.261

Review 4.  Senescence, apoptosis and therapy--cutting the lifelines of cancer.

Authors:  Clemens A Schmitt
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

5.  Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.

Authors:  B W Kristensen; J Noraberg; B Jakobsen; J B Gramsbergen; B Ebert; J Zimmer
Journal:  Brain Res       Date:  1999-09-11       Impact factor: 3.252

6.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

Review 7.  Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures.

Authors:  Randy L Jensen
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

8.  Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.

Authors:  Håkon Reikvam; Kimberley J Hatfield; Anne M Oyan; Karl H Kalland; Astrid O Kittang; Oystein Bruserud
Journal:  Eur J Haematol       Date:  2009-11-17       Impact factor: 2.997

9.  Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death.

Authors:  Elena Favaro; Giorgia Nardo; Luca Persano; Massimo Masiero; Lidia Moserle; Rita Zamarchi; Elisabetta Rossi; Giovanni Esposito; Mario Plebani; Ulrike Sattler; Thomas Mann; Wolfgang Mueller-Klieser; Vincenzo Ciminale; Alberto Amadori; Stefano Indraccolo
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

10.  Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival.

Authors:  Elise Lambert; Cédric Boudot; Zahra Kadri; Mahdhia Soula-Rothhut; Marie-Line Sowa; Patrick Mayeux; William Hornebeck; Bernard Haye; Emmanuelle Petitfrere
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

View more
  64 in total

1.  Clinical value of CD133 and nestin in patients with glioma: a population-based study.

Authors:  Rikke H Dahlrot; Steinbjørn Hansen; Stine S Jensen; Henrik D Schrøder; Jacob Hjelmborg; Bjarne W Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids.

Authors:  T Rosenberg; M Thomassen; S S Jensen; M J Larsen; K P Sørensen; S K Hermansen; T A Kruse; B W Kristensen
Journal:  CNS Oncol       Date:  2015

3.  Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation.

Authors:  Heike Peterziel; Julia Müller; Andreas Danner; Sebastian Barbus; Hai-Kun Liu; Bernhard Radlwimmer; Torsten Pietsch; Peter Lichter; Günther Schütz; Jochen Hess; Peter Angel
Journal:  Neuro Oncol       Date:  2012-03-06       Impact factor: 12.300

Review 4.  Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.

Authors:  Sean Mahase; Rachel N Rattenni; Pieter Wesseling; William Leenders; Clarissa Baldotto; Rajan Jain; David Zagzag
Journal:  Am J Pathol       Date:  2017-03-09       Impact factor: 4.307

5.  CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α).

Authors:  Chuanyang Sun; Hui Song; Hua Zhang; Chuansheng Hou; Tianhang Zhai; Lv Huang; Liang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-22       Impact factor: 4.553

6.  Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma.

Authors:  Simon K Hermansen; Karina G Christensen; Stine S Jensen; Bjarne W Kristensen
Journal:  J Histochem Cytochem       Date:  2011-04       Impact factor: 2.479

Review 7.  The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates.

Authors:  Suojun Zhang; Xiao Luo; Feng Wan; Ting Lei
Journal:  Neurochem Res       Date:  2012-09-19       Impact factor: 3.996

8.  Cancer Stem Cells under Hypoxia as a Chemoresistance Factor in Breast and Brain.

Authors:  Spencer W Crowder; Daniel A Balikov; Yu-Shik Hwang; Hak-Joon Sung
Journal:  Curr Pathobiol Rep       Date:  2014-03

Review 9.  The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.

Authors:  Catherine J Libby; Anh Nhat Tran; Sarah E Scott; Corinne Griguer; Anita B Hjelmeland
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 10.680

10.  miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.

Authors:  Lijoy K Mathew; Nicolas Skuli; Vera Mucaj; Samuel S Lee; Pascal O Zinn; Pratheesh Sathyan; Hongxia Z Imtiyaz; Zhongfa Zhang; Ramana V Davuluri; Shilpa Rao; Sriram Venneti; Priti Lal; Justin D Lathia; Jeremy N Rich; Brian Keith; Andy J Minn; M Celeste Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.